drugset / Trial / NCT02859246
Mucinex® for Treatment of Filamentary Keratitis
NaSingle-groupOpen-labelTreatment
Summary
It is a pilot study aimed to determine if oral Mucinex® is effective in reducing the amount of corneal filaments and improving symptomology in subjects with filamentary keratitis.
Timeline
- Start
- 2016-09
- Primary completion
- 2018-07
- Completion
- 2018-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guaifenesin | Small molecule | 600 mg | Oral |